|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.44 USD | -1.31% |
|
+5.20% | -30.41% |
| Capitalization | 7.42B 6.31B 5.91B 5.55B 10.22B 674B 11.17B 68.87B 26.62B 317B 27.86B 27.27B 1,153B | P/E ratio 2025 * |
15.6x | P/E ratio 2026 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise value | 11.68B 9.93B 9.29B 8.73B 16.08B 1,059B 17.57B 108B 41.87B 499B 43.82B 42.9B 1,813B | EV / Sales 2025 * |
1.32x | EV / Sales 2026 * | 1.32x |
| Free-Float |
51.55% | Yield 2025 * |
5.1% | Yield 2026 * | 5.25% |
Last Transcript: Eastman Chemical Company
| 1 day | -1.35% | ||
| 1 week | +5.20% | ||
| Current month | +2.37% | ||
| 1 month | +10.54% | ||
| 3 months | -2.46% | ||
| 6 months | -17.51% | ||
| Current year | -30.41% |
| 1 week | 60.2 |  | 66.1 |
| 1 month | 56.11 | | 66.1 |
| Current year | 56.11 | | 103.82 |
| 1 year | 56.11 | | 103.82 |
| 3 years | 56.11 | | 114.5 |
| 5 years | 56.11 | | 130.47 |
| 10 years | 34.44 | | 130.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Costa
CEO | Chief Executive Officer | 59 | 31/12/2013 |
William McLain
DFI | Director of Finance/CFO | 53 | 27/02/2020 |
Stephen Crawford
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/12/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Renée Hornbaker
BRD | Director/Board Member | 71 | 31/08/2003 |
Mark Costa
CHM | Chairman | 59 | 29/06/2014 |
Humberto Alfonso
BRD | Director/Board Member | 67 | 03/01/2011 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.79% | 624 M€ | +6.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.31% | +5.20% | -34.12% | -22.82% | 7.42B | |
| -1.42% | +1.10% | +4.66% | +78.88% | 74.66B | |
| +1.82% | -5.33% | -22.53% | +5.50% | 35.61B | |
| +1.75% | +2.72% | -28.23% | -29.69% | 32.21B | |
| +0.46% | +7.11% | +1.75% | +44.14% | 26.81B | |
| -1.59% | +7.21% | +72.89% | -23.63% | 18.8B | |
| -0.96% | +0.31% | +54.35% | +126.99% | 16.71B | |
| +0.55% | +2.80% | -10.90% | -13.29% | 16.12B | |
| -0.38% | +4.36% | +33.35% | -44.81% | 15.62B | |
| +2.48% | +10.19% | +36.09% | +17.31% | 13.33B | |
| Average | +0.25% | +2.20% | +10.73% | +13.86% | 25.73B | |
| Weighted average by Cap. | +0.15% | +1.21% | +5.97% | +27.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 8.82B 7.5B 7.02B 6.59B 12.15B 800B 13.27B 81.84B 31.63B 377B 33.1B 32.41B 1,370B | 8.88B 7.55B 7.07B 6.64B 12.23B 806B 13.36B 82.38B 31.84B 379B 33.32B 32.62B 1,379B |
| Net income | 486M 413M 386M 363M 669M 44.05B 730M 4.5B 1.74B 20.73B 1.82B 1.78B 75.39B | 701M 596M 558M 524M 966M 63.62B 1.05B 6.51B 2.51B 29.95B 2.63B 2.58B 109B |
| Net Debt | 4.25B 3.62B 3.38B 3.18B 5.86B 386B 6.4B 39.46B 15.25B 182B 15.96B 15.62B 660B | 4.34B 3.69B 3.45B 3.24B 5.97B 393B 6.52B 40.21B 15.54B 185B 16.27B 15.92B 673B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/12/25 | 63.56 $ | -1.12% | 682,309 |
| 12/12/25 | 65.12 $ | -1.09% | 2,200,499 |
| 11/12/25 | 65.84 $ | +1.35% | 2,138,316 |
| 10/12/25 | 64.96 $ | +6.13% | 2,018,540 |
| 09/12/25 | 61.21 $ | +1.32% | 2,096,172 |
Delayed Quote Nyse, December 15, 2025 at 05:37 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EMN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition